Flinders Medical Centre

Futó vizsgálatok

• Még nem toboroz

  Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

  NCT07634289· 2. fázis· Olivia Newton-John Cancer Research Institute· Forrás

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· 3. fázis· Takeda· Forrás

• Toboroz

  BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

  NCT07625644· 3. fázis· SystImmune Inc.· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07589634· 2. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of LY3439539 in Participants With Alzheimer's Disease

  NCT07598370· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  NCT07422480· 3. fázis· Takeda· Forrás

• Toboroz

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

  NCT07549412· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Meghívásos bevonás

  An Extension of SKY-0515 in Participants With Huntington's Disease

  NCT07537075· 2/3. fázis· Skyhawk Therapeutics, Inc.· Forrás

• Még nem toboroz

  Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II

  NCT07134712· 2. fázis· HONYA Medical Co Ltd· Forrás

• Toboroz

  A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

  NCT07369076· 1/2. fázis· Nura Bio· Forrás

• Toboroz

  A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

  NCT07235293· 2. fázis· Kahr Bio Australia Pty Ltd· Forrás

• Toboroz

  Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  NCT07195695· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

  NCT06932562· 3. fázis· European Myeloma Network B.V.· Forrás

• Fut, nem toboroz

  A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07170150· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  PRIORITY-CONNECT 2 Trial

  NCT06976710· Surgical Outcomes Research Centre (SOuRCe)· Forrás

• Toboroz

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  NCT06973187· 3. fázis· BeOne Medicines· Forrás

• Toboroz

  OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  NCT07136012· 3. fázis· Amgen· Forrás

• Még nem toboroz

  Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis

  NCT07093268· 1. fázis· Brain Trust Bio· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· 3. fázis· Amgen· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

  NCT06979375· 2. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· 3. fázis· Amgen· Forrás

• Toboroz

  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  NCT06852222· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease

  NCT06873334· 2/3. fázis· Skyhawk Therapeutics, Inc.· Forrás

• Toboroz

  A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

  NCT06876649· 4. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

  NCT06876662· 4. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  NCT06499285· 3. fázis· Takeda· Forrás

• Toboroz

  A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

  NCT06892548· 1/2. fázis· BioNTech SE· Forrás

• Toboroz

  A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

  NCT06846671· 3. fázis· BeOne Medicines· Forrás

• Toboroz

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· 3. fázis· Daiichi Sankyo· Forrás

• Fut, nem toboroz

  Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

  NCT06710132· 1/2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

  NCT06284317· 3. fázis· ETOP IBCSG Partners Foundation· Forrás

• Toboroz

  Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  NCT06712316· 2/3. fázis· BioNTech SE· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  NCT06588478· 2. fázis· Loxo Oncology, Inc.· Forrás

• Még nem toboroz

  Surgery and Reducing Ionizing Radiation of the Unknown Primary

  NCT06578871· 2. fázis· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's· Forrás

• Fut, nem toboroz

  A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

  NCT06588686· 2. fázis· Vicore Pharma AB· Forrás

• Fut, nem toboroz

  Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

  NCT06635824· 3. fázis· Genmab· Forrás

• Toboroz

  CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

  NCT06690775· 2. fázis· TORL Biotherapeutics, LLC· Forrás

• Fut, nem toboroz

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

  NCT06561048· 3. fázis· Corvus Pharmaceuticals, Inc.· Forrás

• Toboroz

  Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

  NCT06441747· 2. fázis· Australasian Gastro-Intestinal Trials Group· Forrás

• Fut, nem toboroz

  A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

  NCT06190951· 2. fázis· Regeneron Pharmaceuticals· Forrás

• Fut, nem toboroz

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· 3. fázis· Boehringer Ingelheim· Forrás

Showing 50 of 126.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák9 toboroz
• Szívelégtelenség6 toboroz
• Vastagbélrák6 toboroz
• Krónikus limfoid leukémia (CLL)5 toboroz
• Amiotrófiás laterálszklerózis (ALS)3 toboroz
• Elhízás3 toboroz
• Koszorúér-betegség3 toboroz
• Máj- és epeúti rák3 toboroz
• Mielodiszplasztikus szindróma (MDS)3 toboroz
• Petefészekrák3 toboroz
• Alzheimer-kór2 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyermekkori daganatok2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Mielóma multiplex2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Zsírmáj (MASLD/MASH)2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Amiloidózis1 toboroz
• Aortic aneurysm1 toboroz
• Aortic stenosis1 toboroz
• Autizmus spektrumzavar1 toboroz
• Crohn-betegség1 toboroz
• Deep vein thrombosis and pulmonary embolism1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Epilepszia1 toboroz
• Familiáris hiperkoleszterinémia1 toboroz
• Follikuláris limfóma1 toboroz
• Glioblasztóma1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Hólyagrák1 toboroz
• Huntington-kór1 toboroz
• Krónikus vesebetegség1 toboroz
• Magas vérnyomás1 toboroz
• Méhtestrák1 toboroz
• Melanóma1 toboroz
• Mild cognitive impairment1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pajzsmirigyrák1 toboroz
• Prosztatarák1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Visszavonták

  Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

  NCT07353957· 2. fázis· Genmab· Forrás

• Leállították

  RolloverTreatment With Triumeq for People With ALS Following the Lighthouse II Trial

  NCT06658977· 3. fázis· Macquarie University, Australia· Forrás

• Leállították

  To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

  NCT06488911· 3. fázis· Intercept Pharmaceuticals· Forrás

• Lezárult

  A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

  NCT05867121· 1. fázis· Genentech, Inc.· Forrás

• Lezárult

  IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)

  NCT05989711· 2. fázis· Altimmune, Inc.· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

  NCT05512377· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

  NCT05505825· 1/2. fázis· Akeso· Forrás

• Lezárult

  A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

  NCT05383352· 1. fázis· Ipsen· Forrás

• Lezárult

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· 2. fázis· Calliditas Therapeutics Suisse SA· Forrás

• Leállították

  Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  NCT05070845· 2. fázis· Pfizer· Forrás

• Leállították

  Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer

  NCT04958785· 2. fázis· Gilead Sciences· Forrás

• Lezárult

  A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

  NCT05081557· AbbVie· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05037929· 2. fázis· Genentech, Inc.· Forrás

• Lezárult

  Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

  NCT04971785· 2. fázis· Gilead Sciences· Forrás

• Lezárult

  RegoNivo vs Standard of Care Chemotherapy in AGOC

  NCT04879368· 3. fázis· Australasian Gastro-Intestinal Trials Group· Forrás

• Lezárult

  Alleviate-HF-2 Study

  NCT04838353· Alleviant Medical, Inc.· Forrás

• Lezárult

  Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer

  NCT04744831· 2. fázis· Daiichi Sankyo· Forrás

• Lezárult

  DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

  NCT04334759· 3. fázis· PrECOG, LLC.· Forrás

• Leállították

  Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

  NCT04093362· 3. fázis· Taiho Oncology, Inc.· Forrás

• Lezárult

  Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

  NCT04472429· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

  NCT04471428· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· 3. fázis· Bayer· Forrás

• Lezárult

  A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

  NCT04513925· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

  NCT04322539· 3. fázis· Hutchison Medipharma Limited· Forrás

• Lezárult

  Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

  NCT04370704· 1/2. fázis· Incyte Corporation· Forrás

• Lezárult

  A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

  NCT04172675· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

  NCT04129502· 3. fázis· Takeda· Forrás

• Toboroz

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· The University of Queensland· Forrás

• Leállították

  A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

  NCT04032704· 2. fázis· Seagen Inc.· Forrás

• Lezárult

  A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

  NCT03821233· 1. fázis· Zymeworks BC Inc.· Forrás

• Lezárult

  ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

  NCT03685448· 2. fázis· Australian and New Zealand Urogenital and Prostate Cancer Trials Group· Forrás

• Lezárult

  A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

  NCT03740529· 1/2. fázis· Loxo Oncology, Inc.· Forrás

• Lezárult

  Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

  NCT03635567· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia

  NCT03616470· 3. fázis· GlycoMimetics Incorporated· Forrás

• Lezárult

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· 3. fázis· CSL Behring· Forrás

• Lezárult

  Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)

  NCT02910583· 2. fázis· Pharmacyclics LLC.· Forrás

• Lezárult

  Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.

  NCT01918215· Flinders University· Forrás

• Lezárult

  A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT01848561· AbbVie· Forrás

• Lezárult

  Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

  NCT00819208· Canadian Cancer Trials Group· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Szisztémás szklerózis (szkleroderma)13 munka · 0 vizsgálat
• Giant cell arteritis4 munka · 0 vizsgálat